Peterson Caryninsider trades

In SEC Form 4 filings, Peterson Caryn is listed as Chief Development Officer of Gossamer Bio, Inc. (GOSS). Peterson Caryn reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Aug 26.

Companies and roles

Company	Role	Transactions	Last filed
GOSSGossamer Bio, Inc.	Chief Development Officer	1	Aug 26

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-26

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
GOSSGossamer Bio, Inc.	Aug 24	Aug 26	A · derivative	5,800,051	$0.18	$1,015,009	5,800,051	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.